NGM Biopharmaceuticals, Inc. (NGM) - Stock Prices, Stock Peers & Analysis

Home
NGM

Company Name	NGM Biopharmaceuticals, Inc.
Symbol	NGM
Currency	USD
Price	1.54
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	128,532,096
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.6 - 4.69
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. David J. Woodhouse Ph.D.
Website	https://www.ngmbio.com

An error occurred while fetching data.

About NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the